Preview

Современная ревматология

Расширенный поиск

Аутовоспалительные синдромы: что необходимо знать ревматологу

https://doi.org/10.14412/1996-7012-2012-728

Полный текст:

Литература

1. <div><p>Fietta P. Autoinflammatory disease: the hereditary periodic fever syndromes. Acta Biol Ateneo Parmense 2004; 75: 92-9.</p><p>Simon A., van der Meer J.W.S. Patogenesis of familial periodic fever syndromes or hereditary inflammatory syndromes. Am J Physiol Regul Integr Comp Physiol 2007; 292: 86-98.</p><p>Reimann H.A. Periodic disease A probable syndrome including periodic fever, benign paroxysmal peritonitis, cyclic neutropenia and intermittent arthralgia. JAMA 1948; 136: 239-44.</p><p>International FMF Consorcium. Ancient missense mutation in a new member of the RoReT gene family are likely to cause Familial Mediterranean Fever. Cell 1997; 90: 797-807.</p><p>French FMF Consorcium. A candidate gene for Familial Mediterranean Fever. J Nat Genet 1997; 17: 25-31.</p><p>Ozen S., Frenkel J., Ruperto N. et al. The Eurofever Project: towards better care for autoinflammatory disease. Eur J Pediatr 2011; 170: 445-52.</p><p>Sarraustede de Mauntiere C., Terriere S., Pugnere D. et al. INFEVERS: the Registry for FMF and hereditary inflammatory disorders mutations. Nucleic Acid Research 2003; 31: 282-5.</p><p>Masters S.L., Simon A., Aksetijevich I. et al. Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease. Ann Rev Immunol 2009; 27: 621-68.</p><p>Кузьмина Н.Н., Федоров Е.С., Мовсисян Г.Р. и др. Аутовоспалительные заболевания - современный взгляд на проблему. Науч.-практ. ревматол. 2009; 1: 63-75.</p><p>Kuijk L.M., Hoffman H.L., Neven B. et al. Episodic Autoinflammatory Disorders in Children. In: Handbook of Systemic Autoimmune Disease. V. 6 Pediatrcs in Systemic Autoimmune Disease. Ed. R. Cimas, Lehman T. Elselvier, 2008; 119—35.</p><p>Drenth G., van der Meer G.W. Hereditary Periodic fever. New Engl J Med 2001; 345(24): 1748-57.</p><p>Ozen S. Familial mediterranean fever: revisiting an ancient disease. Eur J Pediatr 2003; 162: 449-54.</p><p>Амрян Г.Г. Периодическая болезнь у детей: клинико-генетические аспекты и современный подход к лечению. Автореф. дисс. ... докт. мед. наук. Ереванский гос. мед. университет им. М. Гераци. Ереван, 2010.</p><p>Арутюнян В.М., Акопян Г.С. Периодическая болезнь (этиопатогенетические и клинические аспекты). М.: МИА, 2000.</p><p>Grateau G. Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatology 2004; 43: 410-5.</p><p>Drenth G.P., van der Meer G.W. Periodic fever enters the era of molecular diagnosis. Br Med J 2000; 320: 1091-2.</p><p>Lidar M., Livnech A. Familial Mediterranean fever: clinical, molecular and management advancements. Netherlands J Med 2007; 65: 318-24.</p><p>Livneh A., Langevitz P., Zemer D. et al. Criteria for the diagnosis of familial Mediterranean fever. Arthr Rheum 1997; 40: 1879-85.</p><p>Kalinich T., Haffer D., Niehues T. et al. Colchicune Use in Children and Adolescents With Familial Mediterranean Fever: Literature Review and Consensus Statement. Pediatrics 2007; 119: 474-83.</p><p>Ureten K., Calguneri M., Mesut Onat A. et al. Interferon alfa in protracted arthritis of familial Mediterranean fever: a robust altеrnative for synovectomy. Ann Rheum Dis 2004; 64: 1527.</p><p>Frenkel J., Kuijk L., Hofhuis W. et al. Anakinra in colchicin resistant Familial Mediterranean Fever. In: 14th European Paediatric Rheumatology Congress. Sept. 5-9, 2007. Istanbul/Turkey. Abstract book; 252.</p><p>Metyas S., Arkfeld D.G., Forrester D.M. et al. Infliximab treatment of Familial Mediterranean Fever and its effect to secondary AA amyloidisis. J Clin Rheum 2004; 10: 134-7.</p><p>Yuksel S., Yalcinkaya F., Acar B. et al. Clinical improvement with infliximab in a child with amyloidisis secondary to familial Mediterranean fever. Rheumatology 2006; 45: 1307-8.</p><p>Shinkai K., McCalmont T.H., Leslie K.S. Cryopyrin-assotiated periodic syndrome and autoinflammation. Clin Exp Dermat 2007; 33: 1-9.</p><p>Manji G.A., Wang L., Geddes B.J. et al. PYPAF1, a PYRYN-containing Apaf-like protein that assembles with ASC and regulated activation of NF-kappaB. J Biol Chem 2002; 277: 11570-5.</p><p>Toplak N., Frenkel J., Ozen S. An Internatoinal registry on Autoinflammatory diseases: the Eurofever experience. Ann Rheum Dis 2012 doi: 10.1136.</p><p>Козловская Л.В., Рамеев В.В., Янушкевич Т.Н. и др. АА-амилоидоз при синдроме Макла-Уэллса. Тер. арх. 2002; (6): 62-72.</p><p>Jeru I., Duquensnoy P., Fernandes-Alnemri T. et al. Mutation in NALP12 cause hereditary periodic fever syndrome. Proc Natl Acad Sci USA 2008; 105: 1614-9.</p><p>Kile R.L., Rusk H.A. A case of cold urticaria with unusual family history. JAMA 1940; 114: 1067-8.</p><p>Hoffman H.M., Mueller J.L. Broide D.H. et al. Mutation of a new gene encoding a putative pyrin-like protein caused familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001; 29: 301-5.</p><p>Barron K., Athreya B., Kastner D. Periodic fever syndromes and other inherited autoinflammatory diseases in: Textbook of pediatric rheumatology. Ed. Cassidy J.T. et al. 6th ed. Elsevier Saunders, 2011; 642—60.</p><p>Muckle T.J., Wells M. Urticaria, deafness and amyloidosis: a new heredo-familial syndrome. Q J Med 1962; 31: 235-48.</p><p>Dode C., Le Du N., Cuisset L. et al. New mutations of CIAS that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novelmutation underlies both syndrome. Am J Hum Gen 2002; 70: 1498-506.</p><p>Hawkins P.L., Lachmann H.J., Aganna E. et al. Spectrum of Clinical Features in Muckle-Wells Syndrome and Response to Anakinra. Arthr Rheum 2004; 50: 607-12.</p><p>Lorber J. Syndrome for diagnosis: dwarfing, persistently open fontanelle; recurrent meningitis; recurrent subdural effusions with temporary alternate-sided hemiplegia; hightone deafness; visual defect with pseudopapilloedema; slowing intellectual development; recurrent acute polyarthritis; erythema marginatum, splenomegaly and iron-resistant hypochromic anaemia. Proc R Soc Med 1973; 66(11): 1070-1.</p><p>Prieur A.-M., Griscelli G. Arthropathy with rash, chronic meningitis, eye lesions and mental retardation. J Pediatr 1981; 99: 79-83.</p><p>Feldmann J., Prieur A.-M., Quartier P. et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 2002; 71: 198-203.</p><p>Prier A.M., Griscelli G., Lampert F. et al. A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome, a specific entity analised in 30 patients. Scand J Rheumat 1987; 66(Suppl.): 57-68.</p><p>Hassink S.G., Goldsmith D.P. Neonatal onset multisystem inflammatory disease. Arthr Rheum 1983; 26: 668-73.</p><p>Lovell D.J., Bowyer S.L., Solinger A.M. Interleukine-1 Blockade by Anakinra Improves Clinical Symptoms in Patients With Neonatal-Onset Mutisystem Inflammatory Disease. Arthr Rheum 2005; 52: 1283-6.</p><p>Goldbach-Mansky R., Daily N.J., Canna S.W. et al. Neonatal-Onset Mutisystem Inflammatory Disease Responsive to Interleukine-1 Inhibition. New Engl J Med 2006; 355: 581-92.</p><p>Kuemmerle-Deschner G.B., Fizaribacliev N. Muckle-Wells syndrome Effective treatment with Anakinra. Arthr Rheum 2007; 56: 9(Suppl.): 290.</p><p>Goldbach-Mansky R., Shroff S.D., Wilson M. et al. A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome. Arthr Rheum 2008; 58(8): 2432-42.</p><p>Hoffman H.M., Throne M.L., Amar N.J. et al. Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthr Rheum 2008; 58(8): 2443-52.</p><p>Lachmann H., Kone-Paut I., Kuemmerle-Deschner G.B. et al. for the Canakinumab in CAPS Study Group. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med 2009; 360: 2416-25.</p><p>Aksentijevich I., Master S.L., Ferguson P.D. et al. An autoinflammatory disease with Deficiency of the Interleukin-1-Receptor Antagonist. N Engl J Med 2009; 360: 2426-37.</p><p>Goldbach-Mansky R., Kastner D.L. Autoinflammation: The prominent role of IL-1 in monogenic autoinflammatory diseases and implication for common illnesses. J Allergy Clin Immunol 2009; 124: 1141-51.</p><p>Van der Meer J.W.H., Vossen J.M., Radl J. et al. Hyperimmunoglobulinemia D and periodic fever: a new syndrome. Lancet 1984; 1: 1087-90.</p><p>Drenth J.P., Guisset L., Grateau G. et al. Mutation in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. Nat Genet 1999; 22: 178-81.</p><p>Klasen I.S., Goertz J.H.C., van de Wiel G.A.S et al. Hyper-Immunoglibulin A in the Hyperimmunoglobulinemia D syndrome. Clinical and Diagnostic Lab Imm 2001; 8: 58-61.</p><p>Drenth J.P., Powell R.J., Brown N.S. et al. Interferon-gamma and urine neopterin attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Eur J Clin Invest 1995; 25: 683-6.</p><p>Simon A., Drewe E., van der Meer J.W.M. Simvastatin Treatment for Inflammatory Attacks of the Hyperimmunoglobulinemia D and Periodic Fever Syndrome. Simvastatin Treatment for Inflammatory Attacks of the Hyperimmunoglobulinemia D and Periodic Fever Syndrome. Clinical Pharmacology &amp; Therapeutics 2004; 75: 476-83.</p><p>Bodar E.J., van der Hilst J.C., Drent J.P. et al. Effect of etanercept and anakinra on inflammatory attaks in the hyper-Ig D syndrome: introduction a vaccination provocation model. Neth J Med 2005; 63: 260-4.</p><p>Takada K., Aksentjevich G., Mahadevan V. et al. Favorable preliminary experience with Etanercept in two patients with hyperimmunoglobulinemia D syndrome and periodic fever syndrome. Arthr Rheum 2003; 48: 2645-51.</p><p>Nevyjel M., Pontillo A., Calligaris L. et al. Diagnostics and Therapeutic Insights in a Severe Case of Mevalonate Kinase Deficiency. Pediatrics 2007; 119: 523-7.</p><p>Marsha ll G.S., Edwards K.M., Butler J. et al. Syndrome of periodic fever, pharyngitis, and aphthous stomatitis. J Pediatr 1987; 110: 43-6.</p><p>Willamson L.M., Hull K.M., Mehta R. et al. Familial Hibernian fever. Q J Med 1982; 51: 469-80.</p><p>Stjernberg-Salmela S., Ranki A., Karenko et al. The genetic background of Tumor Necrosis Factor-associated periodic syndrome and other systemic autoinflammatory disorders. Scand J Rheum 2004; 33: 133-9.</p><p>Drewe E., Huggis M.L., Morgan A.G. et al. Treatment of renal amyloidosis with etaer-cept in tumor necrosis factor receptor-associated periodic syndrome. Rheumatology 2004; 43: 1405-14.</p><p>Arostegui J.I., Solis P., Aldea A. et al. Etanercept plus colchicines treatment in a child with tumor necrosis factor receptor-associated periodic syndrome abolished auto-inflammatory episodes without normilising the subclinical acute phase response. Eur J Pediatr 2005; 164: 13-6.</p><p>Stojanov S., Hoffman F., Kery A. et al. Cytokine profile in PFAPA syndrome suggest continious inflammation and redused antiinflammatory response. Eur Cytokine Netw 2006; 17: 90-7.</p><p>Feder H.M., Bialecki C.A. Periodic fever associated with aphthous stomatitis, pharyngitis and cervical adenitis. Ped Infect Dis J 1989; 8: 186-7.</p><p>Padeh S., Brezniak N., Zemer D. et al. Periodic fever, aphthous stomatitis, pharyngitis and adenopathy syndrome: clinical characteristics and outcome. J Pediatr 1999; 135: 98-101.</p><p>Giedeon A., Holthusen W., Masel L.F. et al. Subacute and chronic symmetrical osteomyelitis. Ann Radiol 1972; 15: 329-42.</p><p>Gustavson K.H., Willbrand H.F. Symmetric osteomyelitis. Acta Radiol 1974; 15: 551-7.</p><p>Bjorksten B., Gustavson K.H., Eriksson B. et al. Chronic recurrent multifocal osteomyelitis and pustulosis palmoplantaris. J Pediatr 1978; 93: 227-31.</p><p>Girschick H.J., Raab P., Surbaum S. et al. Chronicnon-bacterial steomyelitis in children. Ann Rheum Dis 2005; 64: 279-85.</p><p>Vittecoq O., Ait Said L., Michot C. et al. Evolution of recurrent multifocal osteitis toward spondyloartropathy over long term. Arth Rheum 2000; 43: 109-19.</p><p>Miettunen P.M., Wei X., Kaura D. et al. Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic reccurent muktifocal ostomyelitis. Pediatr Rheum Online J 2009; 7: 2.</p><p>Wise C.A., Gillum J.D., Seideman C.E. Mutation in CD2BP discript binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 2002; 11: 961-9.</p><p>Yeon H.B., Lindor N.M., Seideman J.G. et al. C.E. Pyogen arthritis, pyoderma gangrenosum and acne syndrome maps to chromosome 15q. Am J Hum Gen 2000; 66: 1443-8.</p><p>Dierselhuis M.P., Frenkel J., Wulffraat N.M. et al Anakinra for flares of pyogenic arthritis in PAPA syndrome. Rheumatology 2005; 44: 406-8.</p><p>Cortis E., De Benedetty F., Insalaco A. Abnormal production of tumor necrosis (TNF) alfa and clinical efficacy of the TNF inhibitor etanercept in patient with PAPA syndrome. J Pediatrics 2004; 145: 851-5.</p><p>Pascual V., Allantaz F., Arce E. et al. Role of interleukin-1 (IL-1) in the patogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. The J Exp Med 2005; 201(9): 1479—86.</p><p>Drenth J.P.H., van der Meer W.M. The Inflammasome-A Linebacker of Innate Defense. N Engl J Med 2006; 355: 730-2.</p><p>Masters S.L., Simon A., Aksentijevich I. et al. Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammation Disease. Ann Rev Immunol 2009; 27: 621-68.</p></div><br />


Для цитирования:


Федоров Е.С., Салугина С.О., Кузьмина Н.Н. Аутовоспалительные синдромы: что необходимо знать ревматологу. Современная ревматология. 2012;6(2):49-59. https://doi.org/10.14412/1996-7012-2012-728

For citation:


Fedorov E.S., Salugina S.O., Kuzmina N.N. Autoinflammatory syndromes: What a rheumatologist should know. Modern Rheumatology Journal. 2012;6(2):49-59. (In Russ.) https://doi.org/10.14412/1996-7012-2012-728

Просмотров: 953


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)